Aptamer-conjugated superparamagnetic ferroarabinogalactan nanoparticles for targeted magnetodynamic therapy of cancer

doi:10.3390/cancers12010216

Эндаумент фонд ТГУ!
Впиши своё имя в историю университета
- Сделать пожертвование -

Add to "Quick Collection"

Description	Size	Format
Aptamer-conjugated superparamagnetic ferroarabinogalactan nanoparticles for targeted magnetodynamic therapy of cancer	5 MB	Adobe Acrobat PDF	Read	Download
DOI Доступ к ресурсу на сайте издателя			10.3390/cancers12010216

#аптамеры

#арабиногалактан

#ферроарабиногалактан

#магнитодинамическая терапия

#магнитно-резонансная томография

#суперпарамагнитные наночастицы

#таргетная терапия

#онкология

Title: Aptamer-conjugated superparamagnetic ferroarabinogalactan nanoparticles for targeted magnetodynamic therapy of cancer
Creator: Zamay, Tatiana N.
|
Zamay, Galina S.
|
Babkin, Vasily A.
|
Medvedeva, Elena N.
|
Neverova, Nadezhda A.
|
Kirichenko, Andrey K.
|
Zamay, Sergey S.
|
Lapin, Ivan N.
|
Morozov, Evgeny V.
|
Kolovskaya, Olga S.
|
Sokolov, Alexey E.
|
Narodov, Andrey A.
|
Fedorov, Dmitri G.
|
Tomilin, Felix N.
|
Zabluda, Vladimir N.
|
Svetlichnyi, Valerii A.
Date: 2020
DOI: 10.3390/cancers12010216
Description: Nanotechnologies involving physical methods of tumor destruction using functional oligonucleotides are promising for targeted cancer therapy. Our study presents magnetodynamic therapy for selective elimination of tumor cells in vivo using DNA aptamer-functionalized magnetic nanoparticles exposed to a low frequency alternating magnetic field. We developed an enhanced targeting approach of cancer cells with aptamers and arabinogalactan. Aptamers to fibronectin (AS-14) and heat shock cognate 71 kDa protein (AS-42) facilitated the delivery of the nanoparticles to Ehrlich carcinoma cells, and arabinogalactan (AG) promoted internalization through asialoglycoprotein receptors. Specific delivery of the aptamer-modified FeAG nanoparticles to the tumor site was confirmed by magnetic resonance imaging (MRI). After the following treatment with a low frequency alternating magnetic field, AS-FeAG caused cancer cell death in vitro and tumor reduction in vivo. Histological analyses showed mechanical disruption of tumor tissues, total necrosis, cell lysis, and disruption of the extracellular matrix. The enhanced targeted magnetic theranostics with the aptamer conjugated superparamagnetic ferroarabinogalactans opens up a new venue for making biocompatible contrasting agents for MRI imaging and performing non-invasive anti-cancer therapies with a deep penetrated magnetic field.

Relationships: Show Relationship Browser for this Object
collection(s): Сибирский физико-технический институт | Научное управление
Identifier: смотреть в электронном каталоге НБ ТГУ
Type: статьи в журналах
Source: Cancers. 2020. Vol. 12, № 1. P. 216 (1-17)
Language: eng

Created: 25-02-2021

4318 Visitors

3991 Hits

367 Downloads

Научное управление

Сибирский физико-технический институт Aptamer-conjugated superparamagnetic ferroarabinogalactan nanoparticles for targeted magnetodynamic therapy of cancer